(Vanderbilt University Medical Center) By combining the tools of medicinal chemistry and zebrafish biology, a team of Vanderbilt investigators has identified compounds that may offer therapeutic leads for bone-related diseases and cancer.The findings, reported in ACS Chemical Biology, support using zebrafish as a novel platform for drug development.